Victoza Pancreas Injury

Victoza (Liraglutide) is a type 2 diabetes medication in the class of GLP-1 mimicking (incretin) type 2 diabetes drugs.

It is linked to precancerous and cancerous changes in the pancreas. Although Victoza and fellow GLP-1mimicking drugs Byetta and Januvia were prescribed over 33 million times, the FDA has not banned them. Our firm helps those people who have been hurt through no fault of their own after using Victoza.

What Is Victoza?

Victoza is the trade name under which Novo Nordisk sold Liraglutide. It was approved by the U.S. FDA on January 25, 2010 for the treatment of type 2 diabetes.

Victoza helps control blood sugar levels by increasing the amount of insulin that your body produces. It acts as an acylated glucagon-like peptide-1 (GLP-1) agonist which eventually increases insulin secretion and suppresses prandial glucagon secretion.​

How Can Victoza Harm You?

Currently known side effects include less serious side effects such as Headache, Dizziness, Upset Stomach, Rash and Fatigue. More serious side effects include Allergic Reactions (Hives, difficult breathing, swelling of the face, lips, tongue or throat), Renal Failure, Pancreatitis and Pancreatic Cancer. People who are hypersensitive may also experience skin conditions such as Anaphylaxis, Angioderma and Stevens-Johnson syndrome.​

How Can We Help?

The Madeksho Law Firm, PLLC will shoulder the burden of taking on the pharmaceutical industry on behalf of our clients just like it has taken on corporate wrongdoers for over 40 years. If you are prescribed a drug, it should be made safe by adequate warning, adequate research or adequate design. If a drug carries risks, the drug manufacturer should be honest about what those risks are. Call our attorneys today for a free legal consultation and we will explain your rights and how we can help. Attorneys at the Madeksho Law Firm, PLLC will do our duty to keep you informed and protected in a professional, compassionate manner.​